Cargando…

伊布替尼治疗复发/难治原发性自身免疫性溶血性贫血二例——探索性研究

OBJECTIVE: To explore the efficacy and safety of ibrutinib treatment for relapsed/refractory(R/R)primary autoimmune hemolytic anemia(AIHA). METHODS: Two cases of primary AIHA with relapse events were refractory to glucocorticoid, anti-CD20 monoclonal antibody, immunosuppressive drugs, and splenectom...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342072/
https://www.ncbi.nlm.nih.gov/pubmed/32536139
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.05.009